The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Astellas Pharma Inc
Information provided by (Responsible Party):
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT01127516
First received: May 19, 2010
Last updated: May 17, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)